Drug Target Review

JULY 7, 2025

European Directive 2010/63/EU on the protection of animals used for scientific purposes. Throughout her experience in academic research, she gained distinct knowledge and expertise in both disease modelling and biobank building and in the differentiation of iPSCs into cardiac and neuronal cell types. USDA (2020).

Drug Research 52

Drug Research Research Animal Testing Drugs 52

Drug Target Review

FEBRUARY 28, 2024

Prior to that, Mr Ho was at New Leaf Venture Partners, a leading healthcare venture capital firm, where he launched and managed the public investments and cross-over portfolio, and served as its Public Investment Director from 2010 to 2014. Human γδ TCR repertoires in health and disease. References Fichtner A, Ravens S, Prinz I.

Therapies 105

Therapies Engineering Molecular Biology Science 105

Drug Target Review

JUNE 19, 2024

There are many opportunities to address conditions of the eye, such as retinitis pigmentosa, dry age-related macular degeneration or any of the hundreds of inherited retinal diseases. MSTX), from 2010, and was also a member of its board of directors from 2011, until Mast’s merger with Savara, Inc. SVRA) in April 2017.

Therapies 84

Therapies Small Molecule Pharmaceutical Companies Molecular Biology 84

Drug Target Review

FEBRUARY 26, 2024

Alani currently serves as the Herbert Mescon Endowed Professor and Chair of Dermatology at Boston University Chobanian & Avedisan School of Medicine and the Dermatologist-in-Chief at Boston Medical Center, a position she has held since January, 2010.

Therapies 59

Therapies Molecular Biology Medical Schools Regulations 59

Codon

JUNE 18, 2024

Even after a half-century of molecular biology research, scientists didn’t know until recently how gas vesicles physically trap gas while occluding water. Dr. Karl Dussik, an Austrian physician, was among the first to suggest that ultrasound could be used to diagnose diseases within the body in 1941. 31,500x magnification.

Engineering 71

Engineering Laboratories International Clinical Trials 71

Codon

JULY 27, 2023

CNGA3-achromatopsia is a hereditary disease that causes people to see in shades of gray. in Current Biology. They’re talking about a patient who has a rare genetic disease. ” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” From Sulis D.B. in Science.

Therapies 52

Therapies RNA DNA Engineering 52

Codon

JULY 27, 2023

CNGA3-achromatopsia is a hereditary disease that causes people to see in shades of gray. in Current Biology. They’re talking about a patient who has a rare genetic disease. ” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” From Sulis D.B. in Science.

Therapies 52

Therapies RNA DNA Engineering 52